COMP <GO>
TCMD vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Tactile Systems Technology Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: TCMD 8
— UNH 5
■ METRIC PARITY
LAST: $24.31 (+1.67%) • MKT CAP: $550.7M
options-implied-move
—
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
options-implied-move
6.74%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TCMD VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TCMD | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.90% | 88.57% | -12.67 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.10% | 11.47% | +5.63 | TCMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.9x | 16.4x | -1.55 | TCMD | /valuation <GO> |
| Free Cash Flow Yield | 7.34% | 6.48% | +0.86 | TCMD | /fcf-yield <GO> |
| Operating Margin | 8.90% | 4.82% | +4.08 | TCMD | /operating-margins <GO> |
| Net Profit Margin | 5.80% | 3.14% | +2.66 | TCMD | /net-margins <GO> |
| Revenue Growth (YoY) | 12.50% | 6.46% | +6.04 | TCMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.38 | 3.12 | +5.26 | TCMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | TCMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.2 | 59.2 | -9.96 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.3x | 17.1x | +7.21 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $550.7M | $368.83B | -$368.28B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TCMD REV | UNH REV | TCMD GROSS % | UNH GROSS % | TCMD FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $329.5M | $447.57B | 75.9% | 88.7% | $40.4M | $16.07B |
| FY 2024 | $293.0M | $400.28B | 74.0% | 88.3% | $38.3M | $20.70B |
| FY 2023 | $274.4M | $371.62B | — | 89.6% | $35.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TCMD // BETA —
UNH // BETA 0.33